Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	9.42	56.07	64.01	2.57	5.51
Cash & Cash Equivalents	9.42	56.07	64.01	2.57	5.51
Cash Growth	-83.20%	-12.40%	2387.76%	-53.28%	52.72%
Receivables	1.17	1.61	2.01	2.04	1.15
Inventory	0	3.73	1.06	0.78	0.69
Other Current Assets	6.25	-2.08	0.22	0.11	-0.03
Total Current Assets	16.84	59.33	67.3	5.51	7.32
Property, Plant & Equipment	6.32	2.49	2.73	2.74	1.61
Goodwill and Intangibles	74.06	0	0	0	0
Other Long-Term Assets	0.67	2.62	0.39	0.46	0.5
Total Long-Term Assets	81.05	5.11	3.11	3.19	2.11
Total Assets	97.89	64.44	70.42	8.7	9.42
Accounts Payable	6.91	0.97	0.73	0.65	0.68
Current Debt	0.1	0.27	0.25	0.24	0
Other Current Liabilities	8.66	1.03	0.82	0.69	0.44
Total Current Liabilities	15.66	2.27	1.8	1.58	1.12
Long-Term Debt	2.46	0.26	0.52	0.77	0
Other Long-Term Liabilities	4.59	0.64	0.69	0.63	0.62
Total Long-Term Liabilities	7.05	0.9	1.21	1.4	0.62
Total Liabilities	22.71	3.16	3.01	2.98	1.74
Total Debt	2.55	0.52	0.78	1.01	0
Debt Growth	386.83%	-32.47%	-22.79%	-	-
Retained Earnings	-152.44	-98.6	-91.33	-87.94	-84.49
Shareholders' Equity	75.18	61.28	67.41	5.72	7.68
Net Cash / Debt	6.87	55.55	63.23	1.57	5.51
Net Cash / Debt Growth	-87.63%	-12.15%	3932.78%	-71.53%	52.72%
Net Cash Per Share	0.26	3.91	6.09	0.23	0.82
Working Capital	1.17	57.06	65.5	3.93	6.19
Book Value Per Share	2.81	4.32	6.49	0.85	1.15

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).